The head of the plant "Veterinary preparations" announced the increase in production volumes

“We just go into the vacant niches. That is, we used to produce a number of drugs in smaller volumes than now, since there were many players from the European Union. Now we are taking their place,” said the source of “Vizh”.

The expert noted that in 2022 the plant increased shipments to the domestic market by 18%.

The speaker shared his opinion on how to debunk the myth that imported veterinary drugs are better. “By our example, we try to show that Russian medicines are of high quality. We confirm this by the fact that about 34% of the products shipped by our company are exported,” Ivan Yakhaev said, adding that the company's products are present on the markets of 12 countries. Among the promising markets for Russian veterinary products, the speaker named the countries of Asia and Africa.

At the same time, the source of "ViZh" noted an increase in the cost of production of veterinary drugs by an average of 30%. “This is the indexation of wages, and an increase in fees for energy carriers, all together affect the rise in the cost of production. But not as much as the rise in price of raw materials. We quickly found a replacement for components from the European Union, but inside the country, substance manufacturers raise prices quite strongly,” he said.